To realize the potential of precision medicine, genetic information must be amassed on a large scale. High-throughput genotyping studies are crucial for generating this volume of data and identifying disease associations. Currently, microarrays are the platform of choice for genotyping, as they allow investigators to survey millions of markers across disease cohorts or populations.
High-throughput genotyping data hold immense value for pharmacogenomics, consumer genomics, population studies, and clinical practice. These studies can identify not only genetic risk factors for disease, but also the genotypes associated with drug response. Eventually, this information can lead to better health management and more successful treatment strategies.
Microarrays are ideal for large-scale genotyping studies to identify disease associations or characterize populations. Illumina arrays offer several advantages.
Choose from ready-to-use arrays with expertly designed content, or design custom iSelect or semicustom arrays to suit specific research needs. Process and scan arrays with a rapid three-day workflow.*
*Infinium XT offers a two-day workflow option.
Click on the below to view products for each workflow step.
Comprehensive microarray solution for large-scale genotyping with flexible content.Microarray Kit Selector
Find the best kit for your needs based on project type, starting material, and method or application.
Microarray scanner for high-throughput genotyping of thousands of samples per day.Infinium Accessory Kits
Hardware, software, and accessories needed to process multiple array samples in parallel.
Software to help you visualize, analyze, and manage genotyping data.Illumina LIMS
Laboratory information management system for high-throughput array processing and sample tracking.
The Infinium XT microarray workflow is ideal for production-scale genotyping, supporting biobanks and precision medicine initiatives. Each step of the Infinium workflow is optimized in the Infinium XT workflow, reducing the turnaround time from three days to two days.
By linking large-scale genotyping data with clinical records, researchers identified a rare gene variant for myocardial infarctions.Read Interview
This collaborative genotyping effort identified disease-associated genetic markers prevalent in the Hispanic population.Read Interview
Complex diseases result from a combination of genetic and environmental factors. Array and sequencing technologies can help reveal the underpinnings of these diseases. Learn more about complex disease genomics.
From discovery applications to routine screening, microarrays are a powerful tool for analyzing genetic variation. Learn more about microarrays.